Ulrich Steidl Finalizes Senior Leadership Team at Montefiore Einstein Cancer Center
1 report, 1 independent
Updated Oct 15
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ulrich Steidl finalized the senior leadership team at Montefiore Einstein Comprehensive Cancer Center. This team is designed to advance research and programs spanning basic, translational, clinical, and population science. Amit K. Verma moved from Associate Director to Deputy Director of the center.
From prnewswire.com
Why it matters
The appointments are intended to accelerate efforts in helping people survive advanced cancers and identifying the factors that cause certain cancers. The center aims to move progress in cancer research through its elevated colleagues.
From prnewswire.com
Who's involved
- Ulrich SteidlDirector and Vice President of Cancer Medicine at Montefiore Einstein Comprehensive Cancer Center
Keep exploring
The entities involved
Related events
- Discussion on the limits of pharmacotherapy and the role of FDA approvals.
- Steriwave requires FDA approval for US market.
- The FDA requested additional clinical data from Unicycive Therapeutics.
- Adam Craig reported positive results that could support FDA approval for a treatment.
- ADC Therapeutics received accelerated approval for its drug from the FDA.